Clinical Spectrum and Prognosis of Atypical Autosomal Dominant Polycystic Kidney Disease Caused by Monoallelic Pathogenic Variants of IFT140
- PMID: 39732359
- DOI: 10.1053/j.ajkd.2024.10.009
Clinical Spectrum and Prognosis of Atypical Autosomal Dominant Polycystic Kidney Disease Caused by Monoallelic Pathogenic Variants of IFT140
Abstract
Rationale & objective: Monoallelic predicted loss-of-function (pLoF) variants in IFT140 have recently been associated with an autosomal dominant polycystic kidney disease (ADPKD)-like phenotype. This study enhanced the characterization of this phenotype.
Study design: Case series.
Setting & participants: Seventy-five among 2,797 European individuals with ADPKD-like phenotypes who underwent genetic testing that revealed pLoF IFT140-variants.
Findings: The 75 individuals (median age 56 years, 53.3% females) were from 61 families and were found to have 41 different monoallelic pLoF IFT140-variants. The majority of individuals presented with large, exophytic kidney cysts (median total kidney volume, 688mL [IQR, 201-4,139]), and 90.2% were classified using the Mayo Imaging Classification as Mayo Class 2A. Arterial hypertension was present in 50.7% of the individuals (median age at diagnosis, 59 years [IQR, 29-73]). Only 1 patient developed kidney failure (at age 69 years). A significant difference was observed in the age-adjusted estimated glomerular filtration rate (eGFR) between the male and female patients (P<0.001), and 56.3% of the individuals over the age of 60 years had an eGFR of<60mL/min/1.73m2. The estimated genetic prevalence of monoallelic pLoF IFT140 variants was 19.76 (95% CI, 18.8-20.7) and 27.89 (95% CI, 23.8-31.9) per 10,000 in the Genome Aggregation Database and the 100,000 Genomes Project (100kG), respectively. Only cystic kidney disease (ICD-10 Q61) was associated with pLoF IFT140 variants (P = 2.9 × 10-9, odds ratio = 5.6 (95% CI, 3.3-9.2) in 100kG.
Study limitations: Retrospective study; IFT140-related cystic kidney disease may not be diagnosed in younger patients or patients with milder forms.
Conclusions: Individuals with monoallelic IFT140 pLoF variants are likely to develop kidney cysts atypical of classic ADPKD and generally have a favorable kidney prognosis.
Plain-language summary: Monoallelic pathogenic variants in IFT140 have been linked to a spectrum of kidney disease clinically similar to autosomal dominant polycystic kidney disease (ADPKD). This article describes a case series of 75 individuals with ADPKD-IFT140. Affected individuals typically presented with an atypical imaging pattern, had fewer but larger kidney cysts compared with classic ADPKD, and rarely developed liver cysts. Although the kidney prognosis appeared better than in classic ADPKD, 56.3% of individuals over 60 years of age had stage 3 or more severe CKD. Individuals with ADPKD-IFT140 variants are likely to develop kidney cyst patterns atypical of ADPKD. Their kidney prognosis appears favorable.
Keywords: ADPKD-like spectrum; IFT140; autosomal dominant polycystic kidney disease (ADPKD); case series; inherited kidney diseases; kidney function; loss of function variants; monoallelic IFT140-variants; polycystic kidney disease.
Copyright © 2024 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype.Am J Hum Genet. 2022 Jan 6;109(1):136-156. doi: 10.1016/j.ajhg.2021.11.016. Epub 2021 Dec 9. Am J Hum Genet. 2022. PMID: 34890546 Free PMC article.
-
Monoallelic pathogenic IFT140 variants are a common cause of autosomal dominant polycystic kidney disease-spectrum phenotype.Clin Kidney J. 2024 Feb 15;17(2):sfae026. doi: 10.1093/ckj/sfae026. eCollection 2024 Feb. Clin Kidney J. 2024. PMID: 38404363 Free PMC article.
-
Monoallelic Loss-of-Function IFT140 Pathogenic Variants Cause Autosomal Dominant Polycystic Kidney Disease: A Confirmatory Study With Suspicion of an Additional Cardiac Phenotype.Am J Kidney Dis. 2024 May;83(5):688-691. doi: 10.1053/j.ajkd.2023.08.019. Epub 2023 Oct 14. Am J Kidney Dis. 2024. PMID: 37844724
-
Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases.J Am Soc Nephrol. 2018 Jan;29(1):13-23. doi: 10.1681/ASN.2017050483. Epub 2017 Oct 16. J Am Soc Nephrol. 2018. PMID: 29038287 Free PMC article. Review.
-
Autosomal dominant polycystic kidney disease: an overview of recent genetic and clinical advances.Ren Fail. 2025 Dec;47(1):2492374. doi: 10.1080/0886022X.2025.2492374. Epub 2025 Apr 23. Ren Fail. 2025. PMID: 40268755 Free PMC article. Review.
Cited by
-
Clinical Relevance of IFT140 Loss-of-Function Variants in Development of Renal Cysts.Genes (Basel). 2025 Apr 22;16(5):472. doi: 10.3390/genes16050472. Genes (Basel). 2025. PMID: 40428294 Free PMC article.
-
Characterizing the ADPKD-IFT140 Phenotypic Signature With Deep Learning and Advanced Imaging Biomarkers.Kidney Int Rep. 2025 May 7;10(8):2690-2707. doi: 10.1016/j.ekir.2025.04.062. eCollection 2025 Aug. Kidney Int Rep. 2025. PMID: 40814641 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous